Literature DB >> 1731226

Structural basis of latency in plasminogen activator inhibitor-1.

J Mottonen1, A Strand, J Symersky, R M Sweet, D E Danley, K F Geoghegan, R D Gerard, E J Goldsmith.   

Abstract

Human plasminogen activator inhibitor-1 (PAI-1) is the fast-acting inhibitor of tissue plasminogen activator and urokinase and is a member of the serpin family of protease inhibitors. Serpins normally form complexes with their target proteases that dissociate very slowly as cleaved species and then fold into a highly stable inactive state in which the residues that flank the scissile bond (P1 and P1';) are separated by about 70 A. PAI-1 also spontaneously folds into a stable inactive state without cleavage; this state is termed 'latent' because inhibitory activity can be restored through denaturation and renaturation. Here we report the structure of intact latent PAI-1 determined by single-crystal X-ray diffraction to 2.6 A resolution. The three-dimensional structure reveals that residues on the N-terminal side of the primary recognition site are inserted as a central strand of the largest beta sheet, in positions similar to the corresponding residues in the cleaved form of the serpin alpha 1-proteinase inhibitor (alpha 1-PI). Residues C-terminal to the recognition site occupy positions on the surface of the molecule distinct from those of the corresponding residues in cleaved serpins or in the intact inactive serpin homologue, ovalbumin, and its cleavage product, plakalbumin. The structure of latent PAI-1 is similar to one formed after cleavage in other serpins, and the stability of both latent PAI-1 and cleaved serpins may be derived from the same structural features.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1731226     DOI: 10.1038/355270a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  88 in total

1.  Role of Lys335 in the metastability and function of inhibitory serpins.

Authors:  H Im; M H Yu
Journal:  Protein Sci       Date:  2000-05       Impact factor: 6.725

2.  Inactive conformation of the serpin alpha(1)-antichymotrypsin indicates two-stage insertion of the reactive loop: implications for inhibitory function and conformational disease.

Authors:  B Gooptu; B Hazes; W S Chang; T R Dafforn; R W Carrell; R J Read; D A Lomas
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

3.  The use of site-directed fluorophore labeling and donor-donor energy migration to investigate solution structure and dynamics in proteins.

Authors:  F Bergström; P Hägglöf; J Karolin; T Ny; L B Johansson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

4.  Understanding the sequence determinants of conformational switching using protein design.

Authors:  S Dalal; L Regan
Journal:  Protein Sci       Date:  2000-09       Impact factor: 6.725

5.  Topography of a 2.0 A structure of alpha1-antitrypsin reveals targets for rational drug design to prevent conformational disease.

Authors:  P R Elliott; X Y Pei; T R Dafforn; D A Lomas
Journal:  Protein Sci       Date:  2000-07       Impact factor: 6.725

6.  The role of strand 1 of the C beta-sheet in the structure and function of alpha(1)-antitrypsin.

Authors:  S P Bottomley; I D Lawrenson; D Tew; W Dai; J C Whisstock; R N Pike
Journal:  Protein Sci       Date:  2001-12       Impact factor: 6.725

7.  Probing the serpin structural-transition mechanism in ovalbumin mutant R339T by proteolytic-cleavage kinetics of the reactive-centre loop.

Authors:  Yasuhiro Arii; Masaaki Hirose
Journal:  Biochem J       Date:  2002-04-15       Impact factor: 3.857

8.  Bypassing the kinetic trap of serpin protein folding by loop extension.

Authors:  H Im; H Y Ahn; M H Yu
Journal:  Protein Sci       Date:  2000-08       Impact factor: 6.725

9.  Extending the capabilities of targeted molecular dynamics: simulation of a large conformational transition in plasminogen activator inhibitor 1.

Authors:  P Krüger; S Verheyden; P J Declerck; Y Engelborghs
Journal:  Protein Sci       Date:  2001-04       Impact factor: 6.725

10.  The length of the reactive center loop modulates the latency transition of plasminogen activator inhibitor-1.

Authors:  Yu-Ran Na; Hana Im
Journal:  Protein Sci       Date:  2004-12-02       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.